Doshi Maulik S, Patel Prakruti P, Shah Samidh P, Dikshit Ram K
Department of Clinical Pharmacology, Seth G S Medical College and KEM Hospital, Mumbai, India.
J Pharmacol Pharmacother. 2012 Oct;3(4):308-13. doi: 10.4103/0976-500X.103687.
To detect incidence of adverse drug reactions (ADRs) in hospitalized patients and to assess their causality, seriousness, preventability, and the possible economic impact.
This was a prospective study carried out in two medical units at a tertiary care, teaching hospital, for about 18 months. All the admitted patients who developed an ADR after admission (group A) or who were admitted primarily for the treatment of an ADR (group B) were included. Descriptive statistics with 95% CI, χ(2), χ(2) for the trend and kappa test were used.
Out of 6601 patients, 140 patients developed 154 ADRs with an incidence of 2.12%. Causality of the majority of the ADRs in group A was 'possible' while those in group B was 'probable'. Among 109 ADRs (34 serious) in group A, 38 were preventable. On the other hand, out of 45 serious ADRs in group B, 19 were preventable. The total cost of 154 ADRs in 140 patients was Rs. 1,49,803 with an average of Rs. 1070 per patient. The preventable cost for 57/154 ADR was Rs. 96,310.
Around 2% of the hospital patients develop ADRs. A large number of these ADRs were preventable. A substantial saving can be made if adequate caution is exerted.
检测住院患者药物不良反应(ADR)的发生率,并评估其因果关系、严重程度、可预防性以及可能的经济影响。
这是一项在一家三级医疗教学医院的两个医疗科室进行的前瞻性研究,为期约18个月。纳入所有入院后发生ADR的患者(A组)或主要因ADR入院治疗的患者(B组)。采用95%置信区间的描述性统计、χ²检验、趋势χ²检验和kappa检验。
在6601例患者中,140例患者发生了154例ADR,发生率为2.12%。A组大多数ADR的因果关系为“可能”,而B组为“很可能”。A组109例ADR(34例严重)中,38例可预防。另一方面,B组45例严重ADR中,19例可预防。140例患者的154例ADR总费用为149803卢比,平均每位患者1070卢比。154例ADR中57例的可预防费用为96310卢比。
约2%的住院患者发生ADR。其中大量ADR是可预防的。如果足够谨慎,可以节省大量费用。